Biomarkers for dementia in Latin American countries: Gaps and opportunities
Nenhuma Miniatura disponível
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
PARRA, Mario A.
ORELLANA, Paulina
LEON, Tomas
VICTORIA, Cabello G.
HENRIQUEZ, Fernando
GOMEZ, Rodrigo
AVALOS, Constanza
DAMIAN, Andres
SLACHEVSKY, Andrea
IBANEZ, Agustin
Citação
ALZHEIMERS & DEMENTIA, v.19, n.2, p.721-735, 2023
Resumo
Limited knowledge on dementia biomarkers in Latin American and Caribbean (LAC) countries remains a serious barrier. Here, we reported a survey to explore the ongoing work, needs, interests, potential barriers, and opportunities for future studies related to biomarkers. The results show that neuroimaging is the most used biomarker (73%), followed by genetic studies (40%), peripheral fluids biomarkers (31%), and cerebrospinal fluid biomarkers (29%). Regarding barriers in LAC, lack of funding appears to undermine the implementation of biomarkers in clinical or research settings, followed by insufficient infrastructure and training. The survey revealed that despite the above barriers, the region holds a great potential to advance dementia biomarkers research. Considering the unique contributions that LAC could make to this growing field, we highlight the urgent need to expand biomarker research. These insights allowed us to propose an action plan that addresses the recommendations for a biomarker framework recently proposed by regional experts.
Palavras-chave
Referências
- Alawode DOT, 2021, J INTERN MED, V290, P583, DOI 10.1111/joim.13332
- Parra MA, 2021, ALZHEIMERS DEMENT, V17, P295, DOI 10.1002/alz.12202
- Allegri RF, 2021, NEUROLOGIA, V36, P201, DOI 10.1016/j.nrl.2017.12.011
- Allegri RF, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12026
- Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO, DOI 10.1111/J.0963-7214.2004.00293.X
- Aschenbrenner AJ, 2018, NEUROLOGY, V91, pE859, DOI 10.1212/WNL.0000000000006075
- Ashton Nicholas J, 2015, Alzheimers Dement (Amst), V1, P48, DOI 10.1016/j.dadm.2014.11.005
- Baez S, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00253
- Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016
- Bachli MB, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116456
- Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1
- Bobinski M, 2000, NEUROSCIENCE, V95, P721
- Buch KBN, 1999, NEUROSCI LETT, V277, P21
- Cecchini MA, 2021, BRAIN COGNITION, V152, DOI [10.1016/j.bc.2021.105749, 10.1016/j.bandc.2021.105749]
- Coutinho AM, 2020, EUR J NUCL MED MOL I, V47, P2666, DOI 10.1007/s00259-020-04714-0
- Cruts M, 1996, HUM MOL GENET, V5, P1449, DOI 10.1093/hmg/5.Supplement_1.1449
- Cummings J, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0529-5
- Damian A, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.630958
- de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198
- de Souza GS, 2022, MOL IMAGING BIOL, V24, P394, DOI 10.1007/s11307-021-01660-7
- DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
- Di Tella S, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.735508
- Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1
- Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3
- Duran-Aniotz C, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.663407
- El Kadmiri N, 2018, NEUROSCIENCE, V370, P181, DOI 10.1016/j.neuroscience.2017.07.017
- Reyes-Pablo AE, 2020, J ALZHEIMERS DIS, V76, P853, DOI 10.3233/JAD-191015
- Faria DD, 2019, BRAZ J PSYCHIAT, V41, P101, DOI 10.1590/1516-4446-2017-0002
- Goate A, 2006, J ALZHEIMERS DIS, V9, P341
- Gullett JM, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.758298
- Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95
- Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006
- Hampel H, 2018, NAT REV NEUROL, V14, P639, DOI 10.1038/s41582-018-0079-7
- Hansen EO, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.716686
- Ibanez A, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.631722
- Ibanez A, 2021, J ALZHEIMERS DIS, V82, pS379, DOI 10.3233/JAD-201384
- Irizarry Michael C, 2004, NeuroRx, V1, P226
- Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923
- Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018
- Khan TK, 2015, J ALZHEIMERS DIS, V44, P729, DOI 10.3233/JAD-142262
- Koychev I, 2017, J ALZHEIMERS DIS, V60, P283, DOI 10.3233/JAD-170129
- LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622
- Lista S, 2013, PROG NEUROBIOL, V101, P1, DOI 10.1016/j.pneurobio.2012.06.007
- Lourenco MV, 2021, J ALZHEIMERS DIS, V82, P1067, DOI 10.3233/JAD-210147
- Lourenco MV, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12034
- Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52
- Madeira C, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00561
- Magaki S, 2014, J AM GERIATR SOC, V62, P1722, DOI 10.1111/jgs.12977
- Manes F, 2016, LANCET NEUROL, V15, P29, DOI 10.1016/S1474-4422(15)00360-9
- Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064
- MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
- Menon MC, 2017, J AM SOC NEPHROL, V28, P735, DOI 10.1681/ASN.2016080858
- Nitrini R, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010362
- Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430
- O'Bryant SE, 2017, ALZHEIMERS DEMENT, V13, P45, DOI 10.1016/j.jalz.2016.09.014
- Ogonowski N, 2022, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.807764
- Ossenkoppele R, 2019, NEUROLOGY, V92, pE601, DOI 10.1212/WNL.0000000000006875
- Parra MA, 2018, NEUROLOGY, V90, P222, DOI 10.1212/WNL.0000000000004897
- Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617
- Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
- Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4
- SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467
- Sexton C, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.633777
- Shiino A, 2021, ALZH DEMENT-DADM, V13, DOI 10.1002/dad2.12246
- Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120
- Slachevsky A, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01866-4
- Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
- Teunissen CE, 2022, LANCET NEUROL, V21, P66, DOI 10.1016/S1474-4422(21)00361-6
- Teunissen CE, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0359-x
- Thambisetty M, 2010, BIOMARK MED, V4, P65, DOI 10.2217/BMM.09.84
- Thijssen EH, 2020, NAT MED, V26, P387, DOI 10.1038/s41591-020-0762-2
- Tutor CA., 2002, World J Nucl Med, V1, P219
- van der Flier WM, 2005, J NEUROL NEUROSUR PS, V76, pV2, DOI 10.1136/jnnp.2005.082867
- Wojsiat J, 2017, BIOMARK MED, V11, P917, DOI 10.2217/bmm-2017-0041
- Wolters FJ, 2020, NEUROLOGY, V95, pE519, DOI 10.1212/WNL.0000000000010022
- World Bank, 2020, List of economies
- Zarow C, 2005, ANN NEUROL, V57, P896, DOI 10.1002/ana.20503
- Zetterberg H., 2022, ACTA NEUROL SCAND, V146, P51, DOI [DOI 10.1111/ANE.13628, 10.1111/ane.13628]
- Zetterberg H, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00430-x
- Zetterberg H, 2021, MOL PSYCHIATR, V26, P296, DOI 10.1038/s41380-020-0721-9
- Zhou Y, 2021, ACS CHEM NEUROSCI, V12, P4209, DOI 10.1021/acschemneuro.1c00472
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/21
Artigos e Materiais de Revistas Científicas - LIM/44
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/21
Artigos e Materiais de Revistas Científicas - LIM/44